Condition
PET/MR
Total Trials
5
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Unknown4
Recruiting1
Clinical Trials (5)
Showing 5 of 5 trials
NCT07079345RecruitingPrimary
PET/MR Multimodal Quantitative Analysis of CBF and CMRGlc in Cerebral Ischemia
NCT04006223Unknown
The Diagnostic Value of Hybrid PET/MR for Systemic Amyloidosis
NCT03756077Unknown
A Study of the Value of Hybrid PET/MR and PET/CT in Prostate Cancer
NCT05003830Unknown
Application of Multi-probe PET/MR Imaging in the Diagnosis and Evaluation of Alzheimer's Disease
NCT03657017Not ApplicableUnknown
PET/MR in Locally Advanced Nasopharyngeal Carcinoma
Showing all 5 trials